These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31845129)
1. E3 ubiquitin ligase CHIP attenuates cellular proliferation and invasion abilities in triple-negative breast cancer cells. Xu J; Wang H; Li W; Liu K; Zhang T; He Z; Guo F Clin Exp Med; 2020 Feb; 20(1):109-119. PubMed ID: 31845129 [TBL] [Abstract][Full Text] [Related]
2. Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Luan H; Mohapatra B; Bielecki TA; Mushtaq I; Mirza S; Jennings TA; Clubb RJ; An W; Ahmed D; El-Ansari R; Storck MD; Mishra NK; Guda C; Sheinin YM; Meza JL; Raja S; Rakha EA; Band V; Band H Cancer Res; 2018 May; 78(10):2524-2535. PubMed ID: 29510992 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion. Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045 [TBL] [Abstract][Full Text] [Related]
5. The ubiquitin ligase CHIP inactivates NF-κB signaling and impairs the ability of migration and invasion in gastric cancer cells. Liu F; Zhou J; Zhou P; Chen W; Guo F Int J Oncol; 2015 May; 46(5):2096-106. PubMed ID: 25672477 [TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51. Liu P; Zhou W; Yang L; Zhang C Chem Biol Interact; 2022 Feb; 354():109798. PubMed ID: 34998818 [TBL] [Abstract][Full Text] [Related]
7. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP. Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352 [TBL] [Abstract][Full Text] [Related]
8. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways. Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040 [TBL] [Abstract][Full Text] [Related]
9. Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine. Nhukeaw T; Temboot P; Hansongnern K; Ratanaphan A BMC Cancer; 2014 Feb; 14():73. PubMed ID: 24507701 [TBL] [Abstract][Full Text] [Related]
10. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism]. He ZX; Li J; Wang QF; Cheng Q; Ni SJ Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756 [No Abstract] [Full Text] [Related]
11. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Hamurcu Z; Ashour A; Kahraman N; Ozpolat B Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606 [TBL] [Abstract][Full Text] [Related]
12. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331 [TBL] [Abstract][Full Text] [Related]
13. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer. Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
15. Alcohol promotes migration and invasion of triple-negative breast cancer cells through activation of p38 MAPK and JNK. Zhao M; Howard EW; Parris AB; Guo Z; Zhao Q; Yang X Mol Carcinog; 2017 Mar; 56(3):849-862. PubMed ID: 27533114 [TBL] [Abstract][Full Text] [Related]
16. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431 [TBL] [Abstract][Full Text] [Related]
17. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development. Tilli TM; Carels N; Tuszynski JA; Pasdar M Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857 [TBL] [Abstract][Full Text] [Related]
18. Tryptophan hydroxylase 1 and 5-HT Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326 [TBL] [Abstract][Full Text] [Related]
19. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
20. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation. Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]